NPI: 1851477913 · OCONTO FALLS, WI 54154 · Critical Access Hospital · NPI assigned 10/31/2006
Authorized official ALLEN, PATRICIA controls 18+ related entities in our dataset. Read more
| Authorized Official | ALLEN, PATRICIA (CFO) |
| NPI Enumeration Date | 10/31/2006 |
Other providers sharing the same authorized official: ALLEN, PATRICIA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,166 | $590K |
| 2019 | 17,320 | $744K |
| 2020 | 19,037 | $970K |
| 2021 | 25,869 | $1.56M |
| 2022 | 25,878 | $1.60M |
| 2023 | 25,687 | $1.85M |
| 2024 | 16,723 | $1.77M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 1,155 | 983 | $1.99M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 6,056 | 4,616 | $1.27M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,641 | 1,868 | $1.09M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,502 | 4,467 | $986K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,644 | 1,100 | $687K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10,917 | 8,729 | $623K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,922 | 2,531 | $608K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 949 | 744 | $260K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,617 | 1,261 | $257K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,156 | 6,376 | $249K |
| 70450 | Computed tomography, head or brain; without contrast material | 906 | 694 | $225K |
| 80053 | Comprehensive metabolic panel | 8,298 | 5,973 | $186K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,490 | 1,704 | $48K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9,913 | 6,784 | $45K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 162 | 125 | $44K |
| 80306 | 2,585 | 1,908 | $41K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 223 | 168 | $40K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 961 | 856 | $30K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,650 | 1,176 | $29K |
| 97597 | 202 | 87 | $27K | |
| 71046 | Radiologic examination, chest; 2 views | 762 | 597 | $25K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,291 | 1,137 | $21K |
| 80061 | Lipid panel | 1,564 | 1,401 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,089 | 601 | $19K |
| 84484 | 3,321 | 2,106 | $18K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 51 | 12 | $15K |
| 80050 | General health panel | 1,344 | 1,187 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,440 | 1,236 | $12K |
| 81025 | 1,383 | 1,167 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 323 | 251 | $11K |
| 81001 | 5,204 | 3,931 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,136 | 1,645 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,031 | 833 | $11K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 54 | 50 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 188 | 135 | $9K |
| 83690 | 1,928 | 1,436 | $8K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 200 | 153 | $7K |
| 87081 | 620 | 563 | $7K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 29 | 25 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 426 | 181 | $7K |
| 85610 | 2,059 | 1,195 | $6K | |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 22 | 16 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,836 | 2,714 | $6K |
| 83735 | 1,502 | 977 | $5K | |
| 83880 | 340 | 251 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,215 | 685 | $5K |
| 83605 | 1,129 | 680 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 211 | 90 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 166 | 37 | $4K |
| 87486 | 223 | 168 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,850 | 2,693 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 126 | 69 | $4K |
| 87581 | 222 | 167 | $4K | |
| 86140 | 1,117 | 721 | $4K | |
| 71045 | Radiologic examination, chest; single view | 2,043 | 1,508 | $3K |
| 87040 | 1,122 | 426 | $3K | |
| 85379 | 629 | 494 | $3K | |
| 87077 | 722 | 480 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 414 | 304 | $2K |
| 99442 | 154 | 81 | $2K | |
| 90686 | 162 | 157 | $2K | |
| 87186 | 541 | 364 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,486 | 2,163 | $2K |
| 84439 | 213 | 173 | $1K | |
| 73630 | 44 | 41 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 59 | 50 | $1K |
| 85652 | 659 | 420 | $1K | |
| 0004A | 27 | 26 | $967.36 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13 | 13 | $922.25 |
| 74018 | 16 | 13 | $828.37 | |
| 0001A | 18 | 18 | $697.57 | |
| 73030 | 17 | 15 | $618.94 | |
| 36415 | Collection of venous blood by venipuncture | 2,879 | 2,230 | $610.05 |
| 82550 | 112 | 75 | $458.41 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13 | 13 | $434.64 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13 | 13 | $434.64 |
| 0012A | 15 | 13 | $423.96 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 284 | 152 | $413.95 |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,881 | 3,042 | $376.84 |
| 87088 | 91 | 66 | $357.24 | |
| 85730 | 152 | 111 | $272.40 | |
| 87420 | 19 | 17 | $263.58 | |
| J3490 | Unclassified drugs | 2,537 | 969 | $230.34 |
| 81003 | 76 | 65 | $211.94 | |
| 86803 | 14 | 14 | $202.36 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 13 | 13 | $200.91 |
| 99307 | 15 | 14 | $171.96 | |
| 82043 | 17 | 14 | $129.06 | |
| 82962 | 139 | 63 | $126.50 | |
| 87070 | 21 | 13 | $94.37 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,876 | 2,282 | $85.88 |
| 82570 | 16 | 13 | $80.86 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,071 | 1,899 | $78.36 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,419 | 2,258 | $50.14 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,422 | 1,115 | $48.55 |
| J2704 | Injection, propofol, 10 mg | 1,624 | 1,265 | $46.79 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 138 | 110 | $25.90 |
| J1170 | Injection, hydromorphone, up to 4 mg | 115 | 68 | $4.75 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,093 | 854 | $0.84 |
| J7050 | Infusion, normal saline solution, 250 cc | 31 | 15 | $0.00 |
| 96376 | 173 | 84 | $0.00 | |
| A9270 | Non-covered item or service | 434 | 129 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 22 | 12 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 32 | 24 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 81 | 36 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 23 | 13 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 40 | 37 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 51 | 39 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 18 | 13 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 20 | 14 | $0.00 |